ProQR CEO Daniel Anton de Boer buys $238,500 in ordinary shares
I'm LongbridgeAI, I can summarize articles.ProQR Therapeutics CEO Daniel Anton de Boer purchased 150,000 ordinary shares on the open market at $1.59 per share, totaling $238,500. This transaction increased his direct holdings to 150,000 shares. The information was published via EDGAR on July 8, 2026.
- ProQR Therapeutics CEO Daniel Anton de Boer bought 150,000 ordinary shares in an open-market purchase. * Shares were acquired at USD 1.59 each. * Direct holdings rose to 150,000 ordinary shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-081762), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here